Impact of High-Dose Atorvastatin in Coronary Heart Disease Patients Age 65 to 78 Years
نویسندگان
چکیده
منابع مشابه
the role of type-d personality, social support and self-compassion in prediction of health behaviors in coronary heart disease patients
نظر به اهمیت و تاثیر روزافزون عوامل روانی – اجتماعی در سلامت جسمی و تاثیر عوامل روان شناختی در بروز بیماریهای مختلف از جمله بیماریهای قلبی و عروقی این پژوهش با هدف کلی بررسی ارتباط تیپ شخصیتی d ، حمایت اجتماعی و خود دلسوزی در پیش بینی رفتارهای بهداشتی بیماران کرونر قلبی و تعیین تفاوت بین بیماران کرونر قلبی با و بدون جراحی و افراد سالم در این متغیرها و رفتارهای بهداشتی آنان، انجام گرفت. جامعه آ...
15 صفحه اولEvaluation of Apolipoprotein A5 Polymorphism in Coronary- Heart Disease Patients
Background and Objectives: Apolipoprotein A5 (APOA5) gene is important in determining plasma triglyceride levels, a major cardiovascular disease risk factor. Mutation in this gene affected plasma triglyceride level. We looked for possible associations of the APOA5 gene polymorphism S19W with coronary heart disease (CHD) in a sample of Iranian population. Materials and Methods: A total of 7...
متن کاملshort-term therapy with high dose atorvastatin in patients with coronary artery disease can reduce inflammatory process
coronary heart disease is the leading cause of death and disability in adults. the association between acute coronary syndrom (acs) and elevated serum high sensitivity c-reactive protein (hscrp) suggests that chronic inflammation of the coronary arterial wall may play an important role. a number of drugs used in the treatment of cardiovascular disease reduce serum crp. it* is therefore possible...
متن کاملCoronary Heart Disease Phospholipase A2 Enzymes, High-Dose Atorvastatin, and Prediction of Ischemic Events After Acute Coronary Syndromes
placebo group but not in the atorvastatin group. Compared with placebo, atorvastatin reduced median sPLA2 mass ( 32.1% versus 23.1%), sPLA2 activity ( 29.5% versus 19.2%), Lp-PLA2 mass ( 35.8% versus 6.2%), and Lp-PLA2 activity ( 24.3% versus 5.4%; P 0.001 for all). Atorvastatin reduced the hazard of death associated with elevated sPLA2 mass and activity by 50%. Conclusions—sPLA2 mass independe...
متن کاملRisk factors for coronary heart disease in patients below 45 years of age
OBJECTIVE To examine the traditional risk factors and biochemical profile of patients with established CAD (coronary artery disease), and compare the trends of these in specified age groups of different populations as depicted in various studies. METHODOLOGY All consecutive patients below 45 years of age, having classical history of Ischemic heart disease and also having definite ECG changes ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cardiology
سال: 2009
ISSN: 0160-9289,1932-8737
DOI: 10.1002/clc.20448